Ropes & Gray advised QHP Capital L.P. (QHP) on the formation of a single asset continuation fund called the “Catalyst SPV,” backing Catalyst Clinical Research LLC (Catalyst).
QHP is a Raleigh-based private equity firm which manages the NovaQuest Private Equity family of funds. Catalyst is a global contract research organization providing full-service clinical development support for oncology-focused biotechs. The formation was announced on Nov. 1 in a press release.
The Ropes & Gray team that represented QHP was led by asset management partner Peter Laybourn and private equity partners Greg Bauer and Martin Ruhaak. The team also included tax partner Jim Brown.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.